UNSPSC 51172108: Viquidil or viquidil hydrochloride

This classification denotes a quinoline and vasodilator agent with the molecular formulas C20H24N2O2.ClH and C20H24N2O2, preparations that US FDA regulates as active ingredients or moieties under Unique Ingredient Identifiers 48T4S8667S and U6FXT2V136, the base compound being chemically known as 1-propanone, 3-(3-ethenyl-4-piperidinyl)-1-(6-methoxy-4-quinolinyl)-(3r-cis)- but generally known as viquidil, which bears US NIH Compound Identifier 198279.

European Medicines Agency schedules Viquidil hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Indices SUB00081MIG and SUB05109MIG. Most nations schedule viquidil under HS 29392000 and SITC 54142. As of Q4 2014, VIQUIDIL remains the US FDA Preferred Term for this commodity. SMILES: COC1=CC2=C(C=CN=C2C=C1)C(=O)CCC3CCNCC3C=C (base) or COC1CCC2C(C1)C(CCN2)C(=O)CC[C@@H]3CCNC[C@@H]3C=C.CL (hydrochloride).

UNSPSC 51172108 Viquidil or viquidil hydrochloride, a Commodity code, shows limited direct alignment with recent state and local procurement activity. The three recent opportunities bearing this code span offender drug testing, therapeutic pharmacy initiatives, and generic pharmaceutical distribution — none of which explicitly name viquidil as a required input or primary procurement target. Collin County Community Supervision and Corrections Department's RFP 2026-327 for offender specimen collection and drug testing services (due July 23, 2026, estimated contract value $600,000) calls for immunoassay screening with LC/MS/MS or GC/MS confirmation and alternative testing modalities including oral fluid and hair testing, but does not specify viquidil products or reagents by name. The Texas Health and Human Services Commission's RFI HHS0017013 on direct-to-manufacturer prescription programs (posted April 3, 2026) seeks vendor capabilities for establishing direct pharmaceutical contracting but is exploratory in nature with no formal award timeline or budget identified. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) RFP S1070000015802 for generic multi-source pharmaceuticals and OTC products (response deadline March 26, 2026, effective July 1, 2026) covers broad pharmaceutical distribution through authorized wholesalers but does not itemize viquidil by NDC or trade name.

The code shows activity across Texas state agencies and a multistate cooperative purchasing vehicle administered by Minnesota, with no identifiable concentration among issuing bodies or repeated buying patterns specific to viquidil products. The recent opportunities do not establish whether state and local procurement offices regularly source viquidil as a standalone pharmaceutical input, testing reagent, or component of broader pharmaceutical or clinical supply contracts. A business development professional should treat this code as low-signal for direct viquidil procurement and instead monitor whether viquidil appears as a line item in future pharmaceutical or testing-services RFPs under related UNSPSC codes.